Back to Trades
Cohlhepp Ryan
President and COODirectorCIK 0002034665
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 13
- Buy transactions
- 0
- Sell transactions
- 24
- Companies
- 1
- Active
- 2025–2026
Cohlhepp Ryan, President and COO, Director, has filed 13 SEC reports (2025–2026), all concentrated in Bicara Therapeutics Inc. (BCAX), totaling $9.5M in disclosed volume. Weighing $0 bought versus $3.4M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
13 loaded
| Jul 10 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $833.1K |
| Apr 17 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $287.6K |
| Mar 17 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $245.7K |
| Mar 5 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $315.9K |
| Feb 27 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $65.5K |
| Feb 4 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Award | $5.0M |
| Jan 26 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $69.3K |
| Jan 20 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $2.7K |
| Dec 29 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Exercise | $221.8K |
| Dec 16 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $233.5K |
| Nov 25 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $225.6K |
| Oct 16 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $226.9K |
| Oct 8 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $911.8K |
13 filings